Advaxis, Inc.
Cancer vaccine developer completes $3M institutional financing
Published in Health Business Week, March 3rd, 2006
Under the terms of the agreement, signed February 2, 2005, Cornell has committed to provide $3 million of funding in the form of secured convertible debentures having a term of 3 years. Less certain fees and expenses $1.5 million was funded at the first closing of the transaction and an additional $1.5 million less certain fees and expenses will be funded immediately prior to the filing by the company with the Securities and Exchange Commission of a registration statement covering...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2006-03-03)
More Articles from Health Business Week
- Alkermes, Inc.
Risperdal Consta maker reports second consecutive profitable quarter - Allied Healthcare Products, Inc.
Respiratory care product maker posts 72% increase in income - Aphton Corp.
Cancer immunotherapies developer receives delist determination from NASDAQ panel - Applied Imaging Corp.
Medical device maker reaffirms prior guidance for 2005 - Baxter International, Inc.
Infusion pump maker reports earnings of $0.60 per share - Becton, Dickinson & Company
Surgical device maker posts 10% increase in revenue - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
